PL3204492T3 - Sposób generowania komórek progenitorowych limfocytów t - Google Patents

Sposób generowania komórek progenitorowych limfocytów t

Info

Publication number
PL3204492T3
PL3204492T3 PL15771979.0T PL15771979T PL3204492T3 PL 3204492 T3 PL3204492 T3 PL 3204492T3 PL 15771979 T PL15771979 T PL 15771979T PL 3204492 T3 PL3204492 T3 PL 3204492T3
Authority
PL
Poland
Prior art keywords
generating
cell progenitors
progenitors
cell
Prior art date
Application number
PL15771979.0T
Other languages
English (en)
Inventor
Marina Cavazzana
Isabelle ANDRÉ
Chantal LAGRESLE-PEYROU
Salima HACEIN-BEY-ABINA
Christian Reimann
Corinne De Chappedelaine
Emmanuelle SIX
Original Assignee
Assistance Publique-Hôpitaux de Paris
Fondation Imagine - Institut Des Maladies Génétiques
Université Paris Cité
Institut National De La Santé Et De La Recherche Médicale (Inserm)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique-Hôpitaux de Paris, Fondation Imagine - Institut Des Maladies Génétiques, Université Paris Cité, Institut National De La Santé Et De La Recherche Médicale (Inserm) filed Critical Assistance Publique-Hôpitaux de Paris
Publication of PL3204492T3 publication Critical patent/PL3204492T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/42—Notch; Delta; Jagged; Serrate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1114—T cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
PL15771979.0T 2014-10-06 2015-10-05 Sposób generowania komórek progenitorowych limfocytów t PL3204492T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1459539A FR3026744B1 (fr) 2014-10-06 2014-10-06 Methode de generation de progeniteurs de cellules t
PCT/EP2015/072889 WO2016055396A1 (fr) 2014-10-06 2015-10-05 Méthode de génération de progéniteurs de cellules t

Publications (1)

Publication Number Publication Date
PL3204492T3 true PL3204492T3 (pl) 2022-07-25

Family

ID=52102849

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15771979.0T PL3204492T3 (pl) 2014-10-06 2015-10-05 Sposób generowania komórek progenitorowych limfocytów t

Country Status (11)

Country Link
US (1) US12071635B2 (pl)
EP (2) EP3204492B1 (pl)
JP (2) JP6898240B2 (pl)
CA (1) CA2963756C (pl)
DK (1) DK3204492T3 (pl)
ES (1) ES2914082T3 (pl)
FR (1) FR3026744B1 (pl)
HU (1) HUE059468T2 (pl)
PL (1) PL3204492T3 (pl)
PT (1) PT3204492T (pl)
WO (1) WO2016055396A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7049261B2 (ja) 2016-04-08 2022-04-06 ザ ガバニング カウンシル オブ ザ ユニバーシティ オブ トロント 幹細胞および／または前駆細胞からｔ前駆細胞を作製する方法ならびに該ｔ前駆細胞の使用
PT3580330T (pt) 2017-02-13 2022-12-06 Hopitaux Paris Assist Publique Método para gerar progenitores de células t
JP2021514185A (ja) * 2018-02-14 2021-06-10 サニーブルック リサーチ インスティチュート Ｔ細胞系列の細胞を発生させるための方法
AU2019252878B2 (en) * 2018-04-10 2024-02-22 Stichting Sanquin Bloedvoorziening Chimeric Notch receptors
WO2023079082A1 (en) 2021-11-04 2023-05-11 Aphp (Assistance Publique - Hôpitaux De Paris) Method for generating nk cells
WO2024175738A1 (en) 2023-02-22 2024-08-29 Smart Immune Method for thymus regeneration

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093531A (en) 1997-09-29 2000-07-25 Neurospheres Holdings Ltd. Generation of hematopoietic cells from multipotent neural stem cells
WO1999028486A1 (en) 1997-12-04 1999-06-10 Duke University Methods of isolating and using cd7+cd34-lin-hematopoietic cells
EP1666589B1 (en) * 2003-08-22 2010-02-17 Takara Bio Inc. Process for producing cytotoxic lymphocytes
WO2009097140A1 (en) 2008-01-30 2009-08-06 Memorial Sloan-Kettering Cancer Center Methods for off -the -shelf tumor immunotherapy using allogeneic t-cell precursors
CN107595889A (zh) 2008-09-12 2018-01-19 克里奥普拉斯低温生物有限公司 缺血性组织的细胞疗法
EP2352816B1 (en) 2008-11-07 2015-06-24 Sunnybrook Health Sciences Centre Human progenitor t-cells
US8871510B2 (en) * 2009-12-03 2014-10-28 University Of Utah Research Foundation Methods for generating T lymphocytes from hematopoietic stem cells
WO2011127470A1 (en) 2010-04-09 2011-10-13 Fred Hutchinson Cancer Research Center Compositions and methods for providing hematopoietic function without hla matching
US10391126B2 (en) 2011-11-18 2019-08-27 Board Of Regents, The University Of Texas System CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
AU2012347534B2 (en) 2011-12-08 2018-01-25 Fred Hutchinson Cancer Research Center Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
US20150352180A1 (en) * 2013-01-11 2015-12-10 The Trustee Of The University Of Pennsylvania Notch Ligand Bound Biocompatible Substrates And Their Use In Bone Formation
AU2014296059B2 (en) 2013-08-02 2020-12-10 The Regents Of The University Of California Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors
WO2015099134A1 (ja) 2013-12-26 2015-07-02 アストリム株式会社 再構成されたｔ細胞レセプター遺伝子を有する多能性幹細胞由来のｔ前駆細胞を用いる免疫細胞療法
WO2015164594A1 (en) 2014-04-23 2015-10-29 Board Of Regents, The University Of Texas System Chimeric antigen receptors (car) for use in therapy and methods for making the same
US10131876B2 (en) 2014-04-24 2018-11-20 Miltenyi Biotec Gmbh Method for automated generation of genetically modified T cells
US10543257B2 (en) * 2014-09-11 2020-01-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lentiviral vector for treating hemoglobin disorders

Also Published As

Publication number Publication date
EP4036224A1 (fr) 2022-08-03
HUE059468T2 (hu) 2022-12-28
US20180208895A1 (en) 2018-07-26
EP3204492B1 (fr) 2022-03-09
JP2017531448A (ja) 2017-10-26
CA2963756C (fr) 2024-01-02
CA2963756A1 (fr) 2016-04-14
ES2914082T3 (es) 2022-06-07
DK3204492T3 (da) 2022-06-07
EP3204492A1 (fr) 2017-08-16
PT3204492T (pt) 2022-05-30
JP6898240B2 (ja) 2021-07-07
FR3026744B1 (fr) 2024-04-19
FR3026744A1 (fr) 2016-04-08
JP2021072779A (ja) 2021-05-13
WO2016055396A1 (fr) 2016-04-14
US12071635B2 (en) 2024-08-27
ES2914082T8 (es) 2022-06-16

Similar Documents

Publication Publication Date Title
ZA201701648B (en) Cutting apparatus
GB201412018D0 (en) [Apparatus
ZA201606642B (en) An apparatus for producing pouches
GB201416729D0 (en) Apparatus
GB2524307B (en) Apparatus
PT3204492T (pt) Método de geração de progenitores de células t
GB201522268D0 (en) Apparatus for self-injection
GB201417753D0 (en) Apparatus
GB201520650D0 (en) Apparatus
PL3169830T3 (pl) Urządzenie do elektrochlorowania
GB2531031B (en) Apparatus
GB2526278B (en) Apparatus for generating sound
GB2515915B (en) Apparatus
GB201402233D0 (en) Apparatus
ZA201702121B (en) Cutting apparatus
GB201518874D0 (en) Methods for generating spacing members
SG10201507193XA (en) Cutting apparatus
GB2519222B (en) Apparatus
GB201421075D0 (en) Radiation generating apparatus
GB201421074D0 (en) Radiation generating apparatus
IL234388A0 (en) cutting mechanism
AU2014902102A0 (en) Needle disposal apparatus
GB201417943D0 (en) Apparatus
GB201417540D0 (en) Apparatus
GB201416172D0 (en) Apparatus